Matt Hoffman, Associate Editorial Director for NeurologyLive®, has covered medical news for MJH Life Sciences, NeurologyLive®’s parent company, since 2017. He hosts the NeurologyLive® Mind Moments® podcast, as well as the Medical World News show, Deep Dive. Follow him on Twitter @byMattHoffman or email him at email@example.com
FibroGen Completes Enrollment in LELANTOS-2 Trial of Pamrevlumab in Ambulatory DMDJune 9th 2022
The trial is set to read out topline data in the second half of 2023 after completing the target enrollment of 73 patients with Duchenne muscular dystrophy aged 6 to 12 years. The connective tissue growth factor inhibitor has been granted orphan drug, fast track, and rare pediatric disease designations.
Clinical Care Effects of Risdiplam’s Expanded Indication in SMAJune 8th 2022
Richard Finkel, MD, RAINBOWFISH’s principal investigator and the director of the Experimental Neuroscience Program at St. Jude Children’s Research Hospital, offered his take on the recent FDA decision for risdiplam (Evrysdi; Genentech).
Online Shared-Decision Making Tool, MS-SUPPORT, Shows Potential for Increasing DMT Initiation and AdherenceJune 3rd 2022
The online tool was evaluated in a cohort of 501 patients and healthcare providers, showing positive trends in 9 of 11 outcomes assessed. Notably, disease-modifying therapy start, adherence, and long-term mental health were all improved in the intervention group.
EHR-Incorporated MS Smartform Significantly Cuts Down Patient History Review Time in MSJune 2nd 2022
The form, which is freely available through the Epic and Cerner EHR platforms, was developed to streamline and standardize patient data collection to allow clinicians more time with patients and more consistent information.
Women With MS Utilize Social Media to Discuss, Share Safety Concerns on DMT Use During PregnancyJune 1st 2022
Investigators utilized a social media listening tool to evaluate and scale mentions of disease-modifying therapy use by women with multiple sclerosis, with the majority of concerns focused on safety and treatment reinitiation in the postpartum period.
The Future of Care and Focusing on Brain Health in MS to Maximize ReserveMay 30th 2022
Stephen Krieger, MD, of the Icahn School of Medicine and Corinne Goldsmith Dickinson Center for MS at Mount Sinai, shared his perspectives on the trends in multiple sclerosis and the need to holistically treat patients to maximize brain reserve.
CMSC 2022: What to Expect From the Annual MeetingMay 25th 2022
June Halper, MSN, APC-C, MSCN, FAAN, the chief executive officer of the Consortium of Multiple Sclerosis Centers, shared her perspective on what to expect from this year’s annual meeting, which takes place June 1-4, 2022, in National Harbor, Maryland.
AlzoSure Predict Test Shows Predictive Ability for Alzheimer Disease Years Prior to DiagnosisMay 17th 2022
The blood test from Diadem SpA, which quantifies the AZ 284 peptide as readout of U-p53AZ, showed a significantly higher AUC in both time-independent and time-dependent prognostic analyses than gold standard testing.
The Potential of Sleepio and CBT in the Poststroke Recovery ProcessMay 14th 2022
The cofounder and chief scientist at Big Health and professor of sleep medicine at the University of Oxford discussed the recent findings of a study of Sleepio in poststroke rehabilitation and the role that cognitive behavioral therapy could play in that care process.
An AI Morphology Array’s Potential to Improve Parkinson DiagnosisMay 13th 2022
John F. Crary, MD, PhD, and Jerry Fernandez, MD, offer insight into PreciseDx's AI Morphology Feature Array and how this technology can improve neuropathology and diagnosis for neurodegenerative diseases, such as Parkinson disease.
Physicians Express Positivity About Alzheimer Disease Progress, Desire for Improved Dementia Testing PracticesMay 13th 2022
A Harris Poll conducted by Quest Diagnostics suggests that more than 65% of US physicians believe the Alzheimer disease field is on the cusp of a breakthrough, with more than 80% noting that earlier evaluation with blood testing may help improve therapeutic approaches.
Digital CBT Tool Sleepio Improves Sleep in Patients Undergoing Poststroke RehabilitationMay 12th 2022
The digital cognitive behavioral therapy improved sleep for almost half of the study cohort and showed additional signs of improvement for depression and anxiety among individuals in rehabilitation for stroke.
Rapid Progress in ALS: A Reflection of Advances in Neuromuscular Disorder CareMay 12th 2022
With a burst of activity in recent months, the pipeline of development for amyotrophic lateral sclerosis has proven to be a miniature likeness of the wider progress being made in the care and management of neuromuscular disorders.
Steven Wolf, MD, on the State of Lennox-Gastaut Syndrome and the Improving the Diagnostic ProcessMay 8th 2022
The director of the pediatric epilepsy program at Boston Children’s Health Physicians shared his expertise with the challenges associated with diagnosing LGS, how the REST-LGS tool may help, and the need to collect more data.